CHIC2基因缺失(4q12)探針
【簡單介紹】
品牌 | 其他品牌 | 供貨周期 | 現(xiàn)貨 |
---|
本試劑盒主要用于CHIC2基因缺失(4q12)的檢測,里面包括即用型雜交液和DAPI復(fù)染劑。
本試劑盒僅供科研使用。
【詳細(xì)說明】
CHIC2基因缺失(4q12)探針
廣州健侖生物科技?有限公司
本司長期供應(yīng)尼古?。商鎸帲z測試劑盒,其主要品牌包括美國NovaBios、廣州健侖、廣州創(chuàng)侖等進(jìn)口產(chǎn)品,國產(chǎn)產(chǎn)品,試劑盒的實(shí)驗(yàn)方法是膠體金方法。
我司還有很多熒光原位雜交系列檢測試劑盒以及各種FISH基因探針和染色體探針等,。
CHIC2基因缺失(4q12)探針
本試劑盒主要用于CHIC2基因缺失(4q12)的檢測,里面包括即用型雜交液和DAPI復(fù)染劑。
本試劑盒僅供科研使用。
歡迎咨詢
歡迎咨詢
以下是我司出售的部分FISH產(chǎn)品:
BCL6(3q37)基因斷裂探針 |
13/18/21/XY染色體計(jì)數(shù)探針 |
XY染色體計(jì)數(shù)探針 |
p53/RB1/ATM/CSP12/D13S25基因探針 |
5q33/5q31/D7S486/D7S522/CSP8/D20S108/XY基因探針 |
4/10/17/KMT2A[ETV6RUNX1]/[BCRABL(DF)]基因探針 |
p53/D13S319/RB1/1q21/IGH基因探針 |
13/16/18/21/22/XY染色體計(jì)數(shù)探針 |
ALK(2p23)基因斷裂探針 |
EML4/ALK融合基因 t(2;2); inv(2) 探針 |
1p和19q探針 |
KIT(4q12)基因探針(紅色) |
SS18(18q11)(SYT)基因斷裂探針 |
乳腺癌染色體數(shù)目異常檢測探針 |
C-MET(7q31)基因探針 |
CHIC2基因缺失(4q12)探針
二維碼掃一掃
【公司名稱】 廣州健侖生物科技有限公司
【】 楊永漢
【】
【騰訊 】
【公司地址】 廣州清華科技園創(chuàng)新基地番禺石樓鎮(zhèn)創(chuàng)啟路63號(hào)二期2幢101-3室
【企業(yè)文化宣傳】CHIC2基因缺失(4q12)探針
日本理化學(xué)研究所與日本東北大學(xué)的研究小組對(duì)開角型青光眼實(shí)施了全基因組關(guān)聯(lián)分析(GWAS),認(rèn)定了7個(gè)新的易感基因區(qū)域。
青光眼是視神經(jīng)受損的眼病,在日本占失明原因的*位。其主要類型為開角型青光眼,目前對(duì)該病的遺傳因素尚知曉不多。
研究小組發(fā)表在英國《人類分子遺傳學(xué)》雜志上的論文稱,他們利用日本生物銀行收集的3980名開角型青光眼患者和18815名對(duì)照群組為對(duì)象,對(duì)全體人類基因組分布的約600萬個(gè)單核苷酸多態(tài)性(SNP)進(jìn)行了全基因組關(guān)聯(lián)分析。此外,對(duì)已認(rèn)定與開角型青光眼強(qiáng)相關(guān)的SNP,通過兩個(gè)獨(dú)立的群組(患者3398名、對(duì)照組17570名)進(jìn)行了再現(xiàn)性印證。結(jié)果發(fā)現(xiàn),7個(gè)新的基因區(qū)域?qū)η喙庋郯l(fā)病有影響。小組用這些基因區(qū)域與其他人種(患者8357名、對(duì)照組38100名)的發(fā)病風(fēng)險(xiǎn)進(jìn)行驗(yàn)證,認(rèn)定其中2個(gè)SNP參與亞洲系人種、4個(gè)SNP參與歐洲系人種發(fā)病。對(duì)相關(guān)基因特征進(jìn)行路徑分析,查明了上皮生長因子受體信號(hào)相關(guān)基因群影響青光眼發(fā)病。
研究小組還對(duì)過去報(bào)告的開角型青光眼相關(guān)的7種特征進(jìn)行了遺傳學(xué)評(píng)價(jià),發(fā)現(xiàn)開角型青光眼與Ⅱ型糖尿病和心肌梗塞、缺血性中風(fēng)等心血管疾病有共同的遺傳背景,這意味著有些人生來易患此病。他們將進(jìn)一步研究全身狀態(tài)和青光眼的關(guān)系,期望為預(yù)防醫(yī)學(xué)作出貢獻(xiàn)。
The research team of Japanese physicochemical Institute and Tohoku University Japan carried out genome-wide association analysis (GWAS) for open angle glaucoma, and identified 7 new susceptible gene regions.
Glaucoma is the eye disease of the optic nerve, which is the first cause of blindness in Japan. Open angle glaucoma is the main type of glaucoma, and the genetic factors of the disease are not known much at present.
The research team published in the British Journal human molecular genetics, "" the paper said, they use the Japanese bank collected 3980 biological open-angle glaucoma patients and 18815 control group as the object, the whole human genome distribution of about 6 million single nucleotide polymorphisms (SNP) conducted a genome-wide association study. In addition, SNP, which was strongly associated with open angle glaucoma, was reproduced by two independent groups (3398 patients and 17570 controls). The results showed that 7 new gene regions had an impact on the incidence of glaucoma. The team used these gene regions to verify the risk of other races (8357 patients and 38100 controls), and identified 2 SNP participating in Asian race and 4 SNP participating in European race. A path analysis of the related gene features was carried out to determine the influence of the epithelial growth factor receptor signal related gene group on the incidence of glaucoma.
7 features of the past research team also reports of open-angle glaucoma were related genetic evaluation, found open angle glaucoma and stroke of type II diabetes and myocardial infarction, ischemic cardiovascular diseases have common genetic background, which means that some people susceptible to the disease. They will further study the relationship between the state of the body and the glaucoma, and expect to contribute to preventive medicine.
Headline: the Wei Planning Commission held a conference today to invite representatives to discuss the construction of healthy China
The National Health Planning Commission is scheduled to hold a regular conference in February 27th on the theme of "representative members talking about the construction of healthy China". "Healthy China" has been incorporated into the overall development strategy of the country. In view of the ageing of the population, mental stress and medical insurance, the demand for the medical industry will remain stable.
China Network
Title: the Ministry of science and technology: I hope that the annual production of new energy vehicles to double next year
Science and technology minister Wan Gang said on the 26, according to the new energy vehicle development plan, the State Council promulgated in 2020, annual production of new energy vehicles to reach 2 million, that is 2020 in 2018 on the basis of over 1 times, hoping to double next year. To achieve this goal, China has to have a strong ability to innovate.
China new network
Title: new chemical materials to speed up the short board of carbon fiber will be vigorously promote
The Ministry of industry and commerce website released 26 "economic operation of petrochemical and chemical industry in 2017". On the last year, the profit growth rate of Enterprises above the scale was the fastest in 7 years. However, there is still a gap between the domestic high-end chemical products and the world's advanced level. The Ministry said that 2018 will accelerate the implementation of the new chemical materials to make up the short board, the guidance of carbon fiber and composite materials industry alliance, electronic chemicals and new materials industry alliance to carry out the work, to promote the application of carbon fiber, electronic chemicals and materials in the lower area of the film. Promote the establishment of auto lightweight non metal material industry alliance, and promote the application of engineering plastics and carbon fiber composites in the automotive industry. About 80% of China's carbon fiber depends on imports, and the domestic demand is urgent.
Financial circles
Plate hot spots:
Title: Ali or the purchase of all the shares to continue to expand the new retail format and scope
In the afternoon of February 26th, it was reported that the Alibaba had bought all the shares. It is reported that the Alibaba's tablet platform will be merged with the hungry. In the listed companies, the Singapore commercial company, a wholly owned subsidiary of Hualian, has become a shareholder of RajaxHolding with a increase of $90 million. After the increase, the Singapore business company will have the Rajax priority. And Rajax is the main operator of "hungry" brand. Courier courier and hungry to cooperate with logistics transportation.
相關(guān)產(chǎn)品
- FGFR1(8p11)基因斷裂探針
- TFE3(Xp11.2)基因斷裂探針
- RET(10q11)基因斷裂探針
- NTRK1(1q22-q23.1)基因斷裂探針
- TCF3/ PBX1融合基因t (1;19)探針
- CBFB/MYH11融合基因inv (16) t (16;16)探針
- SS18(18q11)(SYT)基因斷裂探針
- EML4/ALK融合基因 t(2;2); inv(2) 探針
- ALK(2p23)基因斷裂探針
- BCL6(3q37)基因斷裂探針
- CCND1(11q13)基因斷裂探針
- MALT1(18q21)基因斷裂探針
- BCL2/IGH融合基因t(14;18)探針
- MYEOV/IGH融合基因t(11;14)探針
- MYC/IGH融合基因t(14;8)探針
- IGH(14q32)基因斷裂探針
- MAFB/IGH融合基因t(14;20)探針
- FGFR3/IGH融合基因t(4;14)探針
- MAF/IGH融合基因t(14;16)探針
- CCND1(BCL1)/IGH融合基因t(11;14)探針
- MYC(8q24)基因斷裂探針
- E2A(19p13)基因斷裂探針
- ETV6(12p13)基因斷裂探針
- ETV6/AML1融合基因 t(12;21) 探針
- AML1(21q22)基因斷裂探針
- RARA(17q21)基因斷裂探針
- CBFB(16q22)基因斷裂探針
- KMT2A(MLL)(11q23)基因斷裂探針
- 廣州創(chuàng)侖PML/RARA融合基因檢測試劑盒熒光原位雜交法
- PML/RARA融合基因t(15;17)探針
- 廣州創(chuàng)侖AML/ETO融合基因檢測試劑盒 熒光原位雜交法
- AML1/ETO融合基因t(8;21)探針
- EVI1(3q26)基因斷裂探針
- ATM(11q22)基因探針
- DLEU1(13q14)基因探針
- PDGFRB(5q32)基因斷裂探針
- CHIC2基因缺失(4q12)探針
- ASS(9q34)基因探針
- BCR ABL(ES)融合基因t(9;22)探針
- BCR ABL(SF)融合基因t(9;22)探針
請(qǐng)輸入產(chǎn)品關(guān)鍵字:
郵編:510660
聯(lián)系人:楊永漢
電話:86-020-82574011
傳真:86-020-32206070
手機(jī):13802525278
留言:發(fā)送留言
個(gè)性化:www.jianlun45.com
網(wǎng)址:www.jianlun.com
商鋪:http://www.hbwxwy.cn/st199246/